Research programme: antifungals - Arrow Therapeutics

Drug Profile

Research programme: antifungals - Arrow Therapeutics

Alternative Names: Antifungals research programme - Arrow Therapeutics

Latest Information Update: 14 Apr 2005

Price : $50

At a glance

  • Originator Arrow Therapeutics
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Mycoses

Most Recent Events

  • 14 Apr 2005 Discontinued - Preclinical for Mycoses in United Kingdom (unspecified route)
  • 31 Mar 2004 This programme is still in active development - (BioSquare-2004)
  • 29 Jan 2001 Preclinical development for Mycoses in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top